Patents by Inventor Janete Cerruti

Janete Cerruti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for distinguishing follicular thyroid adenoma (FTA) from follicular thyroid carcinoma (FTC)
    Patent number: 7927826
    Abstract: Follicular thyroid adenoma (FTA) is distinguished from follicular thyroid carcinoma (FTC) by comparing amount of an expression product of at least one gene selected from the group consisting of DDIT3, ARG2, ITM1, C1orf24, TARSH, and ACO1 in a test follicular thyroid specimen to a normal control thyroid specimen. The test follicular thyroid specimen is identified as FTA if the amount of expression product of TARSH is equal to or greater in the test follicular thyroid specimen than in the normal control thyroid specimen. The test follicular thyroid specimen is identified as FTC if the amount of expression product of DDIT3, ARG2, ITM1, C1orf24, or ACO1 is greater in the test follicular thyroid specimen than in the normal control thyroid specimen.
    Type: Grant
    Filed: December 29, 2009
    Date of Patent: April 19, 2011
    Assignee: Duke University
    Inventors: Gregory J. Riggins, Janete Cerruti
  • Method for distinguishing follicular thyroid adenoma (FTA) from follicular thyroid carcinoma (FTC)
    Patent number: 7645590
    Abstract: Follicular thyroid adenoma (FTA) is distinguished from follicular thyroid carcinoma (FTC) by comparing amount of an expression product of at least one gene selected from the group consisting of DDIT3, ARG2, ITM1, C1orf24, TARSH, and ACO1 in a test follicular thyroid specimen to a normal control thyroid specimen. The test follicular thyroid specimen is identified as FTA if the amount of expression product of TARSH is equal to or greater in the test follicular thyroid specimen than in the normal control thyroid specimen. The test follicular thyroid specimen is identified as FTC if the amount of expression product of DDIT3, ARG2, ITM1, C1orf24, or ACO1 is greater in the test follicular thyroid specimen than in the normal control thyroid specimen.
    Type: Grant
    Filed: December 12, 2007
    Date of Patent: January 12, 2010
    Assignee: Duke University
    Inventors: Gregory J. Riggins, Janete Cerruti
  • Method for distinguishing follicular thyroid adenoma (FTA) from follicular thyroid carcinoma (FTC)
    Patent number: 7319011
    Abstract: Follicular thyroid adenoma (FTA) is distinguished from follicular thyroid carcinoma (FTC) by comparing amount of an expression product of at least one gene selected from the group consisting of DDIT3, ARG2, ITM1, C1orf24, TARSH, and ACO1 in a test follicular thyroid specimen to a normal control thyroid specimen. The test follicular thyroid specimen is identified as FTA if the amount of expression product of TARSH is equal to or greater in the test follicular thyroid specimen than in the normal control thyroid specimen. The test follicular thyroid specimen is identified as FTC if the amount of expression product of DDIT3, ARG2, ITM1, C1orf24, or ACO1 is greater in the test follicular thyroid specimen than in the normal control thyroid specimen.
    Type: Grant
    Filed: April 7, 2005
    Date of Patent: January 15, 2008
    Assignee: Duke University
    Inventors: Gregory J. Riggins, Janete Cerruti
  • Method for distinguishing follicular thyroid adenoma (FTA) from follicular thyroid carcinoma (FTC)
    Publication number: 20060035244
    Abstract: Follicular thyroid adenoma (FTA) is distinguished from follicular thyroid carcinoma (FTC) by comparing amount of an expression product of at least one gene selected from the group consisting of DDIT3, ARG2, ITM1, Clorf24, TARSH, and ACO1 in a test follicular thyroid specimen to a normal control thyroid specimen. The test follicular thyroid specimen is identified as FTA if the amount of expression product of TARSH is equal to or greater in the test follicular thyroid specimen than in the normal control thyroid specimen. The test follicular thyroid specimen is identified as FTC if the amount of expression product of DDIT3, ARG2, ITM1, Clorf24, or ACO1 is greater in the test follicular thyroid specimen than in the normal control thyroid specimen.
    Type: Application
    Filed: April 7, 2005
    Publication date: February 16, 2006
    Applicant: Duke University
    Inventors: Gregory Riggins, Janete Cerruti